Rxsight Inc (RXST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2025 | 12-2024 | 09-2024 | 06-2024 | 03-2024 | |
| Sales | 37,895 | 40,214 | 35,314 | 34,887 | 29,512 |
| Cost of Goods | 9,566 | 11,426 | 10,094 | 10,637 | 8,827 |
| Gross Profit | 28,329 | 28,788 | 25,220 | 24,250 | 20,685 |
| Operating Expenses | 39,569 | 37,843 | 34,540 | 33,220 | 32,182 |
| Operating Income | -10,674 | -8,629 | -9,226 | -8,333 | -10,670 |
| Interest Expense | 6 | 4 | 5 | 6 | 6 |
| Other Income | 2,508 | 2,707 | 2,906 | 2,276 | 1,585 |
| Pre-tax Income | -8,172 | -5,926 | -6,325 | -6,063 | -9,091 |
| Income Tax | 18 | 12 | 13 | 16 | 9 |
| Net Income Continuous | -8,190 | -5,938 | -6,338 | -6,079 | -9,100 |
| Net Income | $-8,190 | $-5,938 | $-6,338 | $-6,079 | $-9,100 |
| EPS Basic Total Ops | -0.20 | -0.14 | -0.16 | -0.16 | -0.25 |
| EPS Basic Continuous Ops | -0.20 | -0.14 | -0.16 | -0.16 | -0.25 |
| EPS Diluted Total Ops | -0.20 | -0.14 | -0.16 | -0.16 | -0.25 |
| EPS Diluted Continuous Ops | -0.20 | -0.14 | -0.16 | -0.16 | -0.25 |
| EPS Diluted Before Non-Recurring Items | -0.20 | -0.15 | -0.16 | N/A | N/A |
| EBITDA(a) | $-12,300 | $-10,783 | $-10,856 | $-9,586 | $-11,035 |